On Marvell's (MRVL) Call: Guides Q3 Sales, Adj-EPS
Tweet
Share
E-mailGet Alerts MRVL Hot Sheet
Price: $237.04 -5.57%
EPS Growth %: +38.8%
Financial Fact:
Total operating costs and expenses: 571.47M
Today's EPS Names:
BTTX, VAXX, ELYS, More
EPS Growth %: +38.8%
Financial Fact:
Total operating costs and expenses: 571.47M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
On its conference call, Marvell (Nasdaq: MRVL) sees Q3 sales of $940-$980 million, which compares to the Street estimate of $958.1 million. Adj-EPS are expected to come in at 39-43 cents, vs. the consensus of 42 cents.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Starts Marvell (MRVL) at Outperform
- Oppenheimer Reiterates Outperform Rating on Marvell (MRVL) Amid Google Deal
- JPMorgan Reiterates Overweight Rating on Marvell (MRVL)
Create E-mail Alert Related Categories
Conference Calls, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
